Ledger.Open graph →
SEC Form D · Amendment · filed March 15, 2019

DMC Biotechnologies, Inc

Offering
$2.5M
Sold
$2.5M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
BOULDER, CO
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (12)

Michael D. Lynch · Boulder, CODirectorCarolyn D. Fritz · Boulder, CODirectorRob D. Van Der Meij · Boulder, CODirectorMatthew L. Lipscomb · Boulder, COExec · DirectorHarlan M. Peltz · Los Angeles, CADirectorAndrew M. Peltz · Los Angeles, CAExec · DirectorCarla R. Hartzenberg · Vancouver, British Columbia, CanadaDirectorBrian M. Good · Los Angeles, CADirectorRonghui Gu · New York, NYDirectorZhong Shao · New York, NYDirectorMuhan Zou · New York, NYExec · DirectorManivannan Shanmugam · Frisco, TXDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗